Bluestein Ventures Winter 2024 Newsletter

Bluestein Ventures Q3 2023 Newsletter

Previous
Previous

Chicago Food VC Bluestein Ventures Closes $45 Million Fund III And Onboards Former RXBar Exec To Strengthen Operations

Next
Next

BiomeSense Featured in the WSJ For Its Key Role in an NIH-Funded Nutrition Study